Top Markets
#1 ADO Protocol ADO Protocol +329.72%
#2 GoPlus Security GoPlus Security +51.65%
#3 Nockchain Nockchain +47.38%
#4 Tutorial Tutorial +42.31%
#5 Starpower Starpower +33.22%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.91%
#7 The Black Bull The Black Bull +27.75%
#8 GAIB AID GAIB AID +24.67%
#9 Casper Network Casper Network +17.77%
#10 Verus Coin Verus Coin +16.89%
Coin of the day
ADO Protocol ADO Protocol
Настройки
Язык
Pусский
Валюта
USD
Тема
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
Ранг среди акций #33299
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
Цена акции
$0.4264
Последняя синхронизация: 2022-09-14
Рыночная капитализация
$7.93M
Изменение (1 день)
-16.44%
Изменение (1 год)
0.00%
Страна
US
Торговля Caladrius Biosciences, Inc. (CLBS)

Категория

Healthcare
Коэффициент P/B для Caladrius Biosciences, Inc. (CLBS)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Caladrius Biosciences, Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Caladrius Biosciences, Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE